John P. Sfakianos, MD, discusses the rationale for evaluating mitomycin intravesical solution in recurrent, low-grade, intermediate-risk NMIBC.
John P. Sfakianos, MD
Advertisement
Articles by John P. Sfakianos, MD
John P. Sfakianos, MD, discusses the importance of restaging transurethral resection of bladder tumors.
Advertisement
Latest Updated Articles
Dr. Sfakianos on Importance of Restaging Transurethral Resection of Bladder TumorsPublished: May 12th 2020 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Daratumumab and Hyaluronidase Plus VRd for Newly Diagnosed Multiple Myeloma
2
PD-L1 Expression Is More Predictive of Response to Pembrolizumab on Metastatic Sites in High-Grade Serous Ovarian Cancer
3
Dr Braunstein on the FDA Approval of Subcutaneous Daratumumab With VRd For Newly Diagnosed Multiple Myeloma
4
Ixazomib-Containing Combinations Signal Potential for More PI-Based Regimens in R/R Multiple Myeloma
5